Dec 19 Imprimis Pharmaceuticals Inc -
* Has agreed to sell an aggregate of approximately 5.1 million units at a purchase price of $1.915 per unit
* Anticipates using net proceeds from transaction primarily to advance ophthalmology business
* Imprimis Pharmaceuticals announces $9.8 million private placement of units Source text for Eikon: Further company coverage:
MIDEAST STOCKS - Factors to watch - May 24
DUBAI, May 24 Here are some factors that may affect Middle East stock markets on Wednesday. Reuters has not verified the press reports and does not vouch for their accuracy.
BRIEF-Canadian Natural Resources prices C$1.8 bln in 3, 9.5 and 30 year medium-term notes
* Canadian Natural Resources Limited prices C$1.8 billion in 3, 9.5 and 30 year medium-term notes